Cost-utility analysis of treating mild stage normal tension glaucoma by surgery in China: a decision-analytic Markov model

被引：0
|
作者：
Di Song
Liwen Wang
机构：
[1] The First People’s Hospital of Huzhou,Department of Ophthalmology
[2] The First Affiliated Hospital of Huzhou Teacher College,undefined
[3] Huzhou Central Hospital,undefined
[4] Affiliated Central Hospital Huzhou University,undefined
来源：
Cost Effectiveness and Resource Allocation | / 22卷
关键词：
Cost-utility analysis; Normal-tension glaucoma; Trabeculectomy; Markov model;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] Spinal cord stimulation for failed back surgery syndrome: A decision-analytic model and cost-effectiveness analysis
    Taylor, RJ
    Taylor, RS
    [J]. INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE, 2005, 21 (03) : 351 - 358
  • [22] Cost Effectiveness of Gene Expression Profiling for Early Stage Breast Cancer A Decision-Analytic Model
    Reed, Shelby D.
    Lyman, Gary H.
    [J]. CANCER, 2012, 118 (24) : 6298 - 6299
  • [23] Cost-utility Analysis of Rhegmatogenous Retinal Detachment Surgery in Shanghai, China
    Ma, Yingyan
    Ying, Xiaohua
    Zou, Haidong
    Xu, Xiaocheng
    Liu, Haiyun
    Bai, Lin
    Xu, Xun
    Zhang, Xi
    [J]. OPHTHALMIC EPIDEMIOLOGY, 2015, 22 (01) : 13 - 19
  • [24] Bimatoprost, latanoprost, and travoprost for the treatment of glaucoma: A cost-effectiveness analysis in Scandinavia using a decision-analytic health economic model
    Stewart, W. C.
    Stewart, J. A.
    Passmore, C. L.
    Mychaskiw, M. A.
    [J]. VALUE IN HEALTH, 2006, 9 (06) : A369 - A370
  • [25] Reply to Cost Effectiveness of Gene Expression Profiling for Early Stage Breast Cancer A Decision-Analytic Model
    Rajan, Suja S.
    Yang, Mo
    Issa, Amalia M.
    [J]. CANCER, 2012, 118 (24) : 6299 - 6300
  • [26] COST-UTILITY ANALYSIS OF ISTENT INJECT IN MILD TO MODERATE PRIMARY OPEN-ANGLE GLAUCOMA IN JAPAN
    Igarashi, A.
    Falvey, H.
    Chu, A.
    Ueyama, M.
    Zhou, J.
    Onishi, Y.
    [J]. VALUE IN HEALTH, 2019, 22 : S671 - S671
  • [27] Sacubitril-Valsartan Compared With Enalapril for the Treatment of Heart Failure: A Decision-Analytic Markov Model Simulation in China
    Wu, Yue
    Tian, Shuo
    Rong, Peipei
    Zhang, Fan
    Chen, Ying
    Guo, Xianxi
    Zhou, Benhong
    [J]. FRONTIERS IN PHARMACOLOGY, 2020, 11
  • [28] COST-UTILITY ANALYSIS OF ANTIHYPERTENSIVE MEDICATIONS IN NIGERIA USING A DECISION ANALYTICAL MODEL
    Ekwunife, O.
    Okafor, C.
    Umeorah, E.
    [J]. VALUE IN HEALTH, 2012, 15 (04) : A123 - A123
  • [29] Cost-effectiveness of ivf treatment in relation to female age and ovarian reserve; results of a markov decision-analytic model
    Moolenaar, L.
    Broekmans, F. B.
    van de Veen, F.
    Fauser, B. C. J. M.
    Hompes, P.
    Mol, B. W.
    [J]. HUMAN REPRODUCTION, 2010, 25 : I156 - I157
  • [30] Latanoprost versus timolol monotherapy for the treatment of glaucoma: A cost-effectivness analysis in Scandinavia and the UK using a decision-analytic health economic model
    Stewart, W. C.
    Stewart, J. A.
    Mychaskiw, M. A.
    [J]. VALUE IN HEALTH, 2006, 9 (06) : A370 - A370
12345